• RA is a chronic inflammatory disorder of autoimmune origin principally attacks the joints, producing a nonsuppurative proliferative and inflammatory synovitis, that progresses to joint destruction and ankylosis • Extraarticular lesions may occur in the skin, heart, blood vessels, and lungs. • It is three times more common in women than in men.
• The peak incidence is in the 3rd - 5th decades of life.
• Pathogenesis:
• RA results from exposure of a genetically susceptible host to
environmental factors. • Genetic susceptibility:
• Association with HLA-DR alleles (DR4, DR1, DRE10, DR14)
and Mycoplasma), and smoking. • Infection and smoking may promote citrullination of self- proteins that trigger autoimmune reactions. • The pathologic changes are mediated by antibodies against self-antigens and inflammation caused by cytokines secreted by CD4+ T cells. • CD4+ T helper (TH) cells initiate the autoimmune response by reacting with an arthritogen, (microbial or a chemically modified self-antigen). • The T cells produce cytokines that stimulate other inflammatory cells to effect tissue injury:
1. IFN-γ from TH1 cells activates macrophages and synovial
cells.
2. IL-17 from TH17 cells recruits neutrophils and monocytes.
3. RANKL expressed on activated T cells stimulates osteoclasts
and bone resorption.
4. TNF and IL-1 from macrophages stimulate resident synovial
cells to secrete proteases that destroy hyaline cartilage. • Antibodies are produced against self antigens (citrullinated peptides). • In RA, complexes of antibodies with citrullinated peptides deposit in the joints. • About 80% of patients have serum IgM or IgA autoantibodies that bind to the Fc portions of their own IgG. • These autoantibodies are called rheumatoid factor. • Morphology:
• Grossly, the synovium becomes edematous, thickened, and
hyperplastic. • Hallmark is synovitis leading to formation of a pannus (a mass of edematous synovium, inflammatory cells, granulation tissue, and fibroblasts • The pannus can bridge apposing bones to form a fibrous ankylosis that will eventually ossify. • The characteristic histologic features include:
1. Synovial cell hyperplasia and proliferation.
2. Dense inflammatory infiltrates of CD4+ helper T cells, B
cells, plasma cells, dendritic cells, and macrophages.
3. Increased vascularity resulting from angiogenesis.
4. Neutrophils and aggregates of organizing fibrin on the
synovial and joint surfaces.
5. Osteoclastic activity in underlying bone causing
periarticular erosions and subchondral cysts. Rheumatoid arthritis. (A) Schematic view of the joint lesion. (B) Low magnification shows marked synovial hypertrophy with formation of villi. (C) At higher magnification, subsynovial tissue containing a dense lymphoid aggregate. • Rheumatoid nodules are an infrequent manifestation of RA and typically occur in subcutaneous tissue including the forearm, elbows, occiput, and lumbosacral area. • Microscopically, they resemble necrotizing granulomas.
• Rarely, RA can involve the lungs (rheumatoid nodules,
are highly specific (~98%) for RA. • There is often anaemia of chronic disease.
• Inflammation causes ↑platelets, ↑ESR, ↑CRP.
• Neutrophils and high protein in synovial fluid.
• X-rays show soft tissue swelling, joint effusions, juxta- articular osteopenia and ↓joint space. • Later there may be bony erosions, subluxation or complete carpal destruction. • Ultrasound and MRI can identify synovitis more accurately, and have greater sensitivity in detecting bone erosions than conventional X-rays. • Complications:
• Anemia of chronic disease
• Secondary amyloidosis.
• Management:
• Corticosteroids, methotrexate, and TNF antagonists.
• NSAIDS
• Physiotherapy
• Surgery may relieve pain, improve function and prevent